Stocks Pedal Backwards as Dow Sheds Triple Digits

This morning's upbeat sentiment was short-lived

Digital Content Manager
Jun 14, 2022 at 12:00 PM
facebook X logo linkedin

Stocks have given up their morning gains at midday, with the Dow Jones Industrial Average (DJI) last seen down 154 points, while the Nasdaq Composite (IXIC) is struggling for direction, and the S&P 500 Index (SPX) is deeper into bear market territory. A slightly lower-than-expected producer price index (PPI) for May initially created some tailwinds, but expectations of a 75-basis-point rate hike later this week have soured investor sentiment once again. 

Continue reading for more on today's market, including: 

  • Buyout offer pushes oil stock to multi-year highs.
  • What sent Oracle stock on a post-earnings surge. 
  • Plus, bears target EQT; REV volatile amid bankruptcy rumors; and OM gets analyst drubbing.

midday stats june 14

EQT Corporation (NYSE:EQT) is seeing an unusual amount of bearish trading in its typically quiet options pits. So far, 6,160 puts have crossed the tape, which is four times the intraday average. The June 41 put is the most popular, with positions being opened there. EQT was last seen down 7.3% at $41.77, and while there is no apparent reason for the negative price action, the natural gas concern is headed for its first close below the 40-day moving average since May 10. Year-to-date, EQT still boasts an over 93% lead.  

eqt june 14

Cosmetics name Revlon Inc (NYSE:REV) is far and away the best performing stock on the New York Stock Exchange (NYSE) today. Last seen up 108.6% at $2.44, the stock is staging a bounce off yesterday's 42.9% drop, after the Wall Street Journal reported the company could file for Chapter 11 bankruptcy as soon as this week. The news sent REV to a record low of $1.08 in the previous session, and even with today's doubling, the stock has lost over 84.3% in the past year. 

One of the worst stocks on the NASDAQ is Outset Medical Inc (NASDAQ:OM). The equity was last seen down 29.2% at $14.46, after Cowen lowered its price target to $33 from $60, while Stifel slashed its price objective to $30 from $55. This comes just one day after the company suspended its guidance and announced a shipment hold on the distribution of its Tablo Hemodialysis System, as approval by the U.S. Food and Drug Administration (FDA) is still pending. The stock earlier hit a record low of $13.67. 


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI